Feedback / Questions
IkT-148009 - Inhibikase, Clintrex
https://www.prnewswire.com/news-releases/inhibikase-therapeutics-announces-publication-demonstrating-potential-for-c-abl-as-a-key-therapeutic-target-in-parkinsons-disease-and-related-disorders-301728359.html
Jan 25, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next